Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating expenses
General and administrative expenses	$ 6,607,045	$ 836,702
Research and development	157,952
Total operating expenses	6,764,997	836,702
Loss from operations	(6,764,997)	(836,702)
Other income (expense)
Inducement expense	(298,714)
Change in fair value of warrant liabilities	3,813,000
Interest expense		(261,759)
Total other income (expense)	3,514,286	(261,759)
Net loss	(3,250,711)	(1,098,461)
Other comprehensive loss
Foreign currency translation	35,736	(12,698)
Comprehensive loss	$ (3,214,975)	$ (1,111,159)
Net loss per share - basic and diluted	$ (0.20)	$ (0.19)
Weighted average shares outstanding, basic and diluted	16,220,661	5,653,820